These innovative medications , Tirzepatide , represent a groundbreaking advancement in addressing obesity and possibly associated ailments . They all are grouped as GLP-1 hormone agonists , meaning they to replicate the natural GLP-1 hormone , stimulating metabolic production and lowering appetit